Ackermans & Van Haaren NV (ACKB)
Euronext Brussels · Belgium · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 253.80 |
|---|---|
| 52-week range | 208.20 – 300.20 |
| Return, 1 month / 3 months | −6.1% / −4.6% |
| Return, 1 year / 3 years | +17.9% / +93.2% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 23.0% |
| Worst drawdown (1 year) | -13.7% |
| Average daily value traded | 7.25M EUR |
| Dividend yield | 1.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Ackermans & Van Haaren is a Belgian diversified holding company based in Antwerp. It owns and manages interests in several businesses, most notably private banking through Delen and Bank J. Van Breda, marine engineering and dredging through DEME, and property development and energy activities. Its customers range from wealthy private clients served by its banks to industrial and public-sector clients of its engineering and contracting businesses. The company takes long-term stakes in these operating companies and supports their management rather than running day-to-day operations itself.
Ackermans & Van Haaren NV trades under the code ACKB on the Euronext Brussels in Belgium, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Ackermans & Van Haaren NV (ACKB) trades on the Euronext Brussels in Belgium. It last closed at EUR 253.80 on 23 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 36 of 111 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 17.9% and over the last three months it fell 4.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Brussels
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -5.2% | ||
| From 52-week high | -14.8% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -4.6% | ||
| 6-month return | -6.9% | ||
| 12-month return, skipping the last month | 25.6% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.7% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 7.25M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 41 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.8% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.5% |
|---|---|
| 1 month | −6.1% |
| 3 months | −4.6% |
| 6 months | −6.9% |
| 1 year | +17.9% |
| 3 years | +93.2% |
| 5 years | +85.4% |
Signals
| 50-day / 200-day average | 265.52 / 267.71 |
|---|---|
| Golden / death cross (60 days) | Death, 8 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.33 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 May 2026 | EUR 4.6000 |
| 29 May 2025 | EUR 3.8000 |
| 30 May 2024 | EUR 3.4000 |
| 29 May 2023 | EUR 3.1000 |
| 30 May 2022 | EUR 2.7500 |
| 27 May 2021 | EUR 2.3500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Brussels; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.